Provided by Tiger Trade Technology Pte. Ltd.

Heron Therapeutics

0.9279
-0.0421-4.34%
Post-market: 0.95400.0261+2.81%17:11 EDT
Volume:1.11M
Turnover:1.03M
Market Cap:175.37M
PE:-7.66
High:0.9700
Open:0.9700
Low:0.9200
Close:0.9700
52wk High:2.61
52wk Low:0.9092
Shares:189.00M
Float Shares:134.00M
Volume Ratio:0.51
T/O Rate:0.83%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1211
EPS(LYR):-0.1211
ROE:-2408.88%
ROA:-0.65%
PB:13.20
PE(LYR):-7.66

Loading ...

Heron Therapeutics Announces Inclusion of APONVIE® (aprepitant) Injectable Emulsion in the Newly Released Fifth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting (PONV)

GlobeNewswire
·
Dec 04, 2025

Heron Therapeutics Inc. Files Initial Statement of Beneficial Ownership for Director Thomas Cusack

Reuters
·
Nov 07, 2025

Heron Therapeutics’ Earnings Call: Growth Amid Challenges

TIPRANKS
·
Nov 05, 2025

Heron Therapeutics price target lowered to $5 from $6 at Jefferies

TIPRANKS
·
Nov 05, 2025

Heron Therapeutics: Buy Rating Affirmed Amid Promising Product Developments and Underappreciated Market Potential

TIPRANKS
·
Nov 05, 2025

Promising Growth and Strategic Initiatives Justify Buy Rating for Heron Therapeutics

TIPRANKS
·
Nov 05, 2025

UPDATE: Heron Therapeutics Q3 Adj. EPS $(0.04) Misses $(0.01) Estimate, Sales $38.213M Miss $39.031M Estimate

Benzinga
·
Nov 04, 2025

Heron Therapeutics reports Q3 2025 net revenue of $38.2 million

Reuters
·
Nov 04, 2025

Heron Therapeutics: Reaffirmed 2025 Net Revenue Guidance

THOMSON REUTERS
·
Nov 04, 2025

Heron Therapeutics Announces Q3 2025 Financial Results and Highlights Commercial Progress

THOMSON REUTERS
·
Nov 04, 2025

Heron Therapeutics Q3 Net Product Sales USD 38.213 Million

THOMSON REUTERS
·
Nov 04, 2025

Heron Therapeutics Q3 Operating Expenses USD 30.392 Million

THOMSON REUTERS
·
Nov 04, 2025

Heron Therapeutics Q3 EPS USD -0.1

THOMSON REUTERS
·
Nov 04, 2025

Heron Therapeutics Inc expected to post a loss of 1 cent a share - Earnings Preview

Reuters
·
Oct 31, 2025

Press Release: Heron Therapeutics Announces Appointment of Thomas Cusack to Board of Directors

Dow Jones
·
Oct 30, 2025

Heron Therapeutics Inc. to Release Third Quarter 2025 Results

Reuters
·
Oct 22, 2025

Heron Therapeutics Inc. Held Special Stockholders' Meeting

Reuters
·
Oct 16, 2025

Heron Therapeutics Inc. Announces Date for Upcoming Special Stockholders Meeting

Reuters
·
Sep 24, 2025

BRIEF-Heron Therapeutics Files For Mixed Shelf Of Up To $125 Million - SEC Filing

Reuters
·
Sep 10, 2025